Content
Week In Review: C-Bridge Raising Another $650 Million For China Healthcare
Article By:
ChinaBio® Today
Read
Saturday, February 3, 2018 4:43 PM EDT
Shanghai's C-Bridge Capital is raising capital for its third healthcare private equity fund with a target of $650 million (see story). Just six months ago, C-Bridge closed its second PE fund at a hard cap of $400 million.
Ply Gem To Be Acquired By Clayton, Dubilier & Rice In Deal Valued At $2.4B
Article By:
The Fly
Read
Wednesday, January 31, 2018 10:07 AM EDT
Ply Gem Holdings and Clayton, Dubilier & Rice announced a definitive agreement under which CD&R funds will acquire all of the outstanding shares of Ply Gem common stock in a go-private transaction valued at approximately $2.4B.
In this article: PGEM
Blackstone To Buy Thomson Reuters’ TRI Unit
Article By:
Samed Olukoya
Read
Tuesday, January 30, 2018 3:39 AM EDT
American multinational private equity firm Blackstone Group LP is in advanced talks to purchase about 55 percent stake in the Financial and Risk Business of Thomson Reuters Corp for over $17 billion, sources familiar with the matter said.
Merger Monday: Keurig Green Mountain Buys Dr Pepper Snapple
Article By:
Tyler Durden
Read
Monday, January 29, 2018 8:40 AM EDT
Dr Pepper Snapple Group and Keurig Green Mountain announced that the two companies will merge to create Keurig Dr Pepper.
In this article: DPS
2018 Could Be "The Year Of M&A"
Article By:
Kevin Mahn
Read
Tuesday, January 23, 2018 1:58 PM EDT
2017 was a good year, but not a great year, for global mergers and acquisition activity as global M&A fell just short of 2016 results with a 3.2% decline in value according to Mergermarket.
Sanofi Acquires Bioverativ For $105 Per Share In Cash, Or $11.6B
Week In Review: Sinocare Eyes $4 Billion Deal For J&J Diabetes Device Business
Article By:
ChinaBio® Today
Read
Saturday, January 20, 2018 5:34 PM EDT
Sinocare, a diabetes company based in Changsha, may bid as much as $4 billion to acquire Johnson & Johnson's diabetes medical device subsidiaries. With falling revenues, some of J&J's diabetes-focused companies are exiting from the US market.
Week In Review: Hua Medicine To Raise $200 Million Through Fundings And IPO For Oral Diabetes Drug
Article By:
ChinaBio® Today
Read
Saturday, January 13, 2018 6:23 PM EDT
Hua Medicine of Shanghai expects to spend $200 million over the next three years on its novel oral diabetes 2 treatment, dorzagliatin. The company will raise additional capital for the effort and then IPO, possibly in Hong Kong or the US.
Week In Review: China Life Science Starts 2018 With $2 Billion Week
Article By:
ChinaBio® Today
Read
Saturday, January 6, 2018 5:40 PM EDT
Perennial Real Estate Holdings announced a $1.2 billion joint venture that will acquire and develop healthcare centers in China. It plans to concentrate on integrated mixed-use developments that are connected to China high speed railway stations.
3 Threats To Amazon You Must Own Today
Article By:
Jeff Yastine
Read
Tuesday, January 2, 2018 3:12 PM EDT
In a wide swath of industries — not just aerospace, but pharmaceuticals, chip manufacturing, packaging, chemicals, consumer goods, media, telecommunications and more — the game of M&A “musical chairs” is already underway.
Meridian Bancorp, Inc. Announces Completion Of Meetinghouse Bancorp, Inc. Acquisition
Article By:
NASDAQ GlobeNewswire
Read
Tuesday, January 2, 2018 11:46 AM EDT
Meridian Bancorp, Inc. announced today that, effective December 29, 2017, it has completed its acquisition of Meetinghouse Bancorp, Inc.
In this article: EBSB
15 Of The Best Mergers And Acquisitions Of 2017
Article By:
Zacks Investment Research
Read
Monday, January 1, 2018 9:30 PM EDT
Merger and acquisition activity in 2017 has been relatively quiet; deals were down 35% year-to-date through mid-November. The deals that were announced in 2017, though, were major,